Advisory Board:
Matthew Geriak, PharmD - Clinical Pharmacist- Investigational Research Pharmacist. Dr. Geriak is a specialized Pharmacist and has a
system-wide position on the Investigational Review Board for Sharp Healthcare. Sharp has 5 hospitals and various clinics throughout
San Diego County. His Drug Research spans from Phase 1 to 4 Human Research Clinical Trials with the focus in the fields of Oncology,
Renal and Heart Transplantations, Septic Shock treatment, Infectious Diseases and Anticoagulation. Mr. Geriak is the primary Investigator
for retrospective cohorts in the field of Infectious Diseases. He also has held positions as a Clinical Pharmacist in the Acute Care
department at Scripps Mercy Hospital in San Diego, and was an infectious Disease Specialist with Sharp HealthCare in San Diego. His
responsibilities were to bring the Antibiotic Stewardship to the next level by developing/mentoring a Pharmacy Residency Infectious
Disease Rotation, round with the ID physicians, create antibiotic utilization guidelines for surgical prophylaxis, and provide entity input
to the system-wide Antimicrobial Review Committee. Education: University of Southern California.
Jessie Kempf - Real Estate Attorney. Mrs. Kempf frequently draws on her experience as a real estate attorney, while helping cannabis
cultivators and distributors grow their businesses. After obtaining a B.A. in Music, a B.A. in History, and a J.D. from UT Austin, Jessie
began her career with Skadden, Arps in Manhattan, where she assisted institutional banks and Fortune 500 companies with highprofile
mergers, financings, and IPOs. She currently works for a real estate boutique in Orange County, helping developers to finance,
acquire, and entitle commercial properties.
In addition to being a member of the California and New York bars, Jessie is actively involved in “Women Grow” and is passionate
about the use of cannabis for medicinal purposes. She’s excited to be working with a team of like-minded individuals at LiveWire,
who are committed to developing technologies and strategies that will shape the future of medical cannabis.
